menu

Medical Program: Assessing Breast Cancer Patient Attitudes Toward Minimal Residual Disease Screening

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Assessing Breast Cancer Patient Attitudes Toward Minimal Residual Disease Screening

close
Assessing Breast Cancer Patient Attitudes Toward Minimal Residual Disease Screening
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Given the sobering statistic that patients treated for breast cancer have a 30 percent lifetime risk of developing incurable, distant metastatic disease, Dr. Matt Birnholz sits down with Isoris Nivar to learn more about his study, which assessed breast cancer survivors’ willingness to know their disseminated tumor cell (DTC) status, undergo bone marrow aspiration, and enroll in a therapeutic trial toward reducing disease recurrence.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Given the sobering statistic that patients treated for breast cancer have a 30 percent lifetime risk of developing incurable, distant metastatic disease, Dr. Matt Birnholz sits down with Isoris Nivar to learn more about his study, which assessed breast cancer survivors’ willingness to know their disseminated tumor cell (DTC) status, undergo bone marrow aspiration, and enroll in a therapeutic trial toward reducing disease recurrence.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 12/5/20